Mode
Text Size
Log in / Sign up

Curcumin fails to significantly lower homocysteine in meta-analysis of 110 participantsCurcumin does not lower homocysteine levels in recent analysis

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Interpret curcumin's lack of significant homocysteine reduction cautiously; avoid standalone use for this indication.

This meta-analysis pooled data from 110 individuals with elevated homocysteine levels, a cardiovascular risk factor, to evaluate the effect of curcumin supplementation versus control on homocysteine (Hcy) levels. The primary analysis found no statistically significant difference between groups (SMD = -2.08, 95% CI -4.67 to 0.51, P = 0.116), with a direction toward decrease but not significant. A sensitivity analysis including an additional study (Rezaei 2024) also showed no significant difference (SMD = -1.23, 95% CI -2.82 to 0.36, P = 0.13).

The authors report very low certainty in these findings due to a small sample size, a high degree of heterogeneity (I2 = 91.6%, P = 0.001), and risk of bias in included studies (one study high risk, one some concerns). Adverse events and follow-up duration were not reported.

Given the limitations, the authors advise that curcumin should not be recommended as a standalone intervention for lowering homocysteine. They note that curcumin's potential role requires confirmation in well-powered trials using optimized, high-bioavailability formulations.

Clinicians should interpret these results cautiously, recognizing that current evidence does not support curcumin for this indication.

How this fits prior evidence

This meta-analysis contrasts with prior preclinical findings on curcumin, which suggested benefits in neuroprotection, bone density, and tumor reduction. Those studies were animal models or mechanistic, whereas this meta-analysis addresses clinical evidence for a cardiovascular risk factor. It extends the curcumin literature by focusing on homocysteine, a gap not covered by prior items. The null result highlights the need for clinical validation, consistent with the cautious framing of earlier coverage.

High levels of homocysteine, a compound in the blood, are often linked to heart health risks. Many people look toward natural supplements like curcumin, a compound found in turmeric, to manage these levels. However, recent research suggests that curcumin might not be the solution many hope for.

Researchers looked at data from 110 people with elevated homocysteine. They compared those taking curcumin to a control group. The results showed no significant difference in homocysteine levels between the two groups. Even when looking closer at specific studies, the change was not large enough to be considered reliable or consistent.

It is important to note that this study had some limitations. The number of people involved was small, and the data from different studies varied greatly. Because of these factors, the evidence is currently very weak. Doctors suggest that curcumin should not be used as a standalone treatment for lowering homocysteine levels.

What this means for you:
Curcumin supplementation does not significantly lower homocysteine levels in people with high levels.

Common questions

Can curcumin help lower high homocysteine levels?

Based on this study of 110 people, curcumin did not show a statistically significant difference in lowering homocysteine levels compared to a control group. Because the evidence is currently very weak due to small sample sizes and inconsistent data, it should not be used as a standalone treatment for this condition.

Is there enough evidence to use curcumin for heart health?

The current evidence is considered very low. The study faced issues like high heterogeneity and a small sample size. While curcumin is often discussed for health, these results suggest it is not a proven way to lower homocysteine levels on its own.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
BackgroundHomocysteine (Hcy) is an established cardiovascular risk factor, and dietary modulation via nutraceuticals represents a promising preventive strategy. Curcumin, a bioactive polyphenol from Curcuma longa L., exhibits pleiotropic biological activities; however, its capacity to reduce circulating Hcy remains uncertain.ObjectivesTo systematically evaluate the effect of curcumin supplementation on Hcy levels.MethodsEight databases were searched from inception to November 2025 for RCTs investigating curcumin and Hcy outcomes. Risk of bias was assessed using Cochrane RoB 2.0. A random-effects model was applied.ResultsThree randomized controlled trials (RCT) with a total of 110 subjects were included in this study. Due to physiologically implausible Hcy values in one study (Rezaei 2024), the primary meta-analysis was restricted to two RCTs with interpretable data (Ghaffari 2017 and Campbell 2019). The results of Meta-analysis showed that compared with the control group, the pooled standardized mean difference SMD = −2.08, 95% confidence interval was −4.67 to 0.51, P = 0.116, there was no statistically significant difference between the two groups. There was a high degree of heterogeneity among the included studies (I2 = 91.6%, P = 0.001). Risk of bias assessment (RoB 2.0) rated one study as low risk, one as some concerns, and one as high risk (selective reporting). Sensitivity analysis that included the study with implausible data (Rezaei 2024) gave a similar non-significant pooled estimate (SMD = −1.23, 95% CI −2.82 to 0.36, P = 0.13; I2 = 91.9%).ConclusionCurrent RCT evidence does not support a statistically significant Hcy-lowering effect of curcumin. The overall certainty of evidence is very low due to small sample size, extreme heterogeneity, and risk of bias. Curcumin should not be recommended as a standalone intervention for lowering Hcy. Its potential role, if any, requires confirmation in well-powered trials using optimized, high-bioavailability formulations.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.